Anson Funds Management LP

Position in OABIW — OmniAb, Inc.

CIK 1491072 DALLAS, TX

Position in OABIW

as of Mar 31, 2026 · filed May 19, 2026 Compact

Position Value

$18,577

-$3,314 QoQ

Shares Held

11,833

0.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Anson Funds Management LP holds $3,230,184 across 4 Biotechnology names. OABIW ranks #4 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SLNO	Soleno Therapeutics Inc	44,231	$1,480,853
2	SPRO	Spero Therapeutics, Inc.	421,956	$987,377
3	YARW	Yarrow Bioscience, Inc.	1,243,106	$743,377
4	OABIW	OmniAb, Inc. This page	11,833	$18,577

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,577	11,833	0.0%	Shares	Defined	2026-05-19
2025-12-31	$21,891	11,833	0.0%	Shares	Defined	2026-02-17
2025-09-30	$18,932	11,833	0.0%	Shares	Defined	2025-11-14
2025-06-30	$20,589	11,833	0.0%	Shares	Defined	2025-08-14
2025-03-31	$28,399	11,833	0.0%	Shares	Defined	2025-05-28
2024-12-31	$41,888	11,833	0.0%	Shares	Defined	2025-02-14
2024-09-30	$50,053	11,833	0.0%	Shares	Defined	2024-11-15
2024-06-30	$44,373	11,833	0.0%	Shares	Defined	2024-08-13
2024-03-31	$64,134	11,833	0.0%	Shares	Defined	2024-05-14
2023-12-31	$73,009	11,833	0.0%	Shares	Defined	2024-02-14
2023-09-30	$61,413	11,833	0.0%	Shares	Defined	2023-11-14
2023-06-30	$59,519	11,833	0.0%	Shares	Defined	2023-08-14
2023-03-31	$43,545	11,833	-84.2%	Shares	Defined	2023-05-19
2022-12-31	$269,455	74,849	—	Shares	Defined	2023-02-13
No filing history on record for this holder in this stock.